WHO GDP AUDIT in Cambodia

Posted by


The World Health Organization (WHO) plays a crucial role in setting global healthcare standards, including Good Distribution Practices (GDP) for pharmaceutical products. In Cambodia, the pharmaceutical industry has witnessed remarkable growth, but ensuring the quality and safety of pharmaceuticals throughout the supply chain remains a challenge. This blog post explores the significance of WHO GDP audits in Cambodia, outlines the key steps to conduct a successful audit, and provides insights into implementing audit recommendations for enhanced regulatory compliance and pharmaceutical quality.

Understanding WHO GDP Audit:

A WHO GDP audit evaluates the adherence of pharmaceutical distribution processes to internationally recognized standards. It aims to ensure the proper storage, transportation, and handling of medicines, ultimately safeguarding public health.

Significance of WHO GDP Audit in Cambodia:

Cambodia’s evolving pharmaceutical sector demands stringent quality control. WHO GDP audits offer a framework to enhance healthcare standards, minimize distribution risks, and align with global practices. These audits also foster trust among consumers and stakeholders, driving the industry’s growth.

Key Steps to Conduct a Successful WHO GDP Audit:

1. Pre-Audit Preparation:

  • Thoroughly review WHO GDP guidelines and requirements.
  • Evaluate existing distribution processes and identify gaps.
  • Develop an audit plan outlining objectives, scope, and team responsibilities.

2. On-Site Audit Procedures:

  • Verify storage conditions, sanitation, and proper documentation.
  • Assess staff training, competence, and adherence to protocols.
  • Conduct a sample-based review of distribution records and practices.

3. Post-Audit Follow-up:

  • Analyze audit findings and categorize issues based on severity.
  • Develop corrective and preventive action plans (CAPA).
  • Implement CAPA with clear timelines and responsible individuals.

Implementing Recommendations from WHO GDP Audit:

  • Prioritize corrective actions to address critical issues promptly.
  • Establish continuous monitoring mechanisms for sustained compliance.
  • Provide regular training and refresher courses to enhance staff competence.


Conducting a WHO GDP audit in Cambodia is a pivotal step towards elevating pharmaceutical quality, ensuring regulatory compliance, and optimizing the healthcare supply chain. By following the outlined steps and embracing audit recommendations, organizations can not only meet international standards but also contribute to the overall advancement of Cambodia’s pharmaceutical sector.

Leave a Reply

Your email address will not be published. Required fields are marked *